• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁稳态与肿瘤发生:分子机制与治疗机遇

Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities.

作者信息

Zhang Caiguo, Zhang Fan

机构信息

Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, 80045, USA,

出版信息

Protein Cell. 2015 Feb;6(2):88-100. doi: 10.1007/s13238-014-0119-z. Epub 2014 Dec 6.

DOI:10.1007/s13238-014-0119-z
PMID:25476483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4312762/
Abstract

Excess iron is tightly associated with tumorigenesis in multiple human cancer types through a variety of mechanisms including catalyzing the formation of mutagenic hydroxyl radicals, regulating DNA replication, repair and cell cycle progression, affecting signal transduction in cancer cells, and acting as an essential nutrient for proliferating tumor cells. Thus, multiple therapeutic strategies based on iron deprivation have been developed in cancer therapy. During the past few years, our understanding of genetic association and molecular mechanisms between iron and tumorigenesis has expanded enormously. In this review, we briefly summarize iron homeostasis in mammals, and discuss recent progresses in understanding the aberrant iron metabolism in numerous cancer types, with a focus on studies revealing altered signal transduction in cancer cells.

摘要

过量铁通过多种机制与多种人类癌症类型的肿瘤发生紧密相关,这些机制包括催化诱变羟基自由基的形成、调节DNA复制、修复和细胞周期进程、影响癌细胞中的信号转导,以及作为增殖肿瘤细胞的必需营养素。因此,癌症治疗中已开发出多种基于铁剥夺的治疗策略。在过去几年中,我们对铁与肿瘤发生之间的遗传关联和分子机制的理解有了极大的扩展。在这篇综述中,我们简要总结了哺乳动物中的铁稳态,并讨论了在理解多种癌症类型中铁代谢异常方面的最新进展,重点是揭示癌细胞中信号转导改变的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5073/4312762/f44823fb62cf/13238_2014_119_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5073/4312762/382a12cd1201/13238_2014_119_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5073/4312762/385143515c85/13238_2014_119_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5073/4312762/7f0a32ff30df/13238_2014_119_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5073/4312762/f44823fb62cf/13238_2014_119_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5073/4312762/382a12cd1201/13238_2014_119_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5073/4312762/385143515c85/13238_2014_119_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5073/4312762/7f0a32ff30df/13238_2014_119_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5073/4312762/f44823fb62cf/13238_2014_119_Fig4_HTML.jpg

相似文献

1
Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities.铁稳态与肿瘤发生:分子机制与治疗机遇
Protein Cell. 2015 Feb;6(2):88-100. doi: 10.1007/s13238-014-0119-z. Epub 2014 Dec 6.
2
A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells.一种有前途的癌症治疗新方法:针对癌症干细胞中的铁代谢。
Semin Cancer Biol. 2018 Dec;53:125-138. doi: 10.1016/j.semcancer.2018.07.009. Epub 2018 Jul 30.
3
Protein lysine acetylation guards metabolic homeostasis to fight against cancer.蛋白质赖氨酸乙酰化保护代谢稳态以对抗癌症。
Oncogene. 2014 May 1;33(18):2279-85. doi: 10.1038/onc.2013.163. Epub 2013 May 13.
4
Macrophage iron homeostasis and polarization in the context of cancer.癌症背景下巨噬细胞的铁稳态与极化
Immunobiology. 2015 Feb;220(2):295-304. doi: 10.1016/j.imbio.2014.09.011. Epub 2014 Sep 16.
5
and Its Potential Influence on Key Oncogenic Pathways.并探讨其对关键致癌途径的潜在影响。
Cells. 2024 Jun 26;13(13):1109. doi: 10.3390/cells13131109.
6
Metabolic alteration in tumorigenesis.肿瘤发生过程中的代谢改变。
Sci China Life Sci. 2013 Dec;56(12):1067-75. doi: 10.1007/s11427-013-4549-2. Epub 2013 Oct 10.
7
p53 tumor suppressor and iron homeostasis.p53 肿瘤抑制因子与铁稳态。
FEBS J. 2019 Feb;286(4):620-629. doi: 10.1111/febs.14638. Epub 2018 Sep 4.
8
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.ZNF217的阴暗面,一种具有强大生物标志物价值的肿瘤发生关键调节因子。
Oncotarget. 2015 Dec 8;6(39):41566-81. doi: 10.18632/oncotarget.5893.
9
Iron homeostasis in breast cancer.乳腺癌中的铁稳态。
Cancer Lett. 2014 May 28;347(1):1-14. doi: 10.1016/j.canlet.2014.01.029. Epub 2014 Jan 31.
10
Sirtuins in Cancer: a Balancing Act between Genome Stability and Metabolism.癌症中的沉默调节蛋白:基因组稳定性与新陈代谢之间的平衡行为
Mol Cells. 2015 Sep;38(9):750-8. doi: 10.14348/molcells.2015.0167. Epub 2015 Sep 18.

引用本文的文献

1
Carnitine Shuttle and Ferroptosis in Cancer.癌症中的肉碱穿梭与铁死亡
Antioxidants (Basel). 2025 Aug 8;14(8):972. doi: 10.3390/antiox14080972.
2
The solute carrier family 11 transporters: a bridge between iron homeostasis and tumor biology.溶质载体家族11转运蛋白:铁稳态与肿瘤生物学之间的桥梁。
Cell Commun Signal. 2025 Jul 10;23(1):332. doi: 10.1186/s12964-025-02293-x.
3
Lactoferrin-A Regulator of Iron Homeostasis and Its Implications in Cancer.乳铁蛋白——铁稳态的调节因子及其在癌症中的意义

本文引用的文献

1
Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.髓样锌指蛋白 1(MZF-1)通过加强铁蛋白介导的铁外排来抑制前列腺肿瘤生长。
Oncogene. 2015 Jul;34(29):3839-47. doi: 10.1038/onc.2014.310. Epub 2014 Oct 6.
2
Proteomic study reveals a functional network of cancer markers in the G1-Stage of the breast cancer cell cycle.蛋白质组学研究揭示了乳腺癌细胞周期G1期癌症标志物的功能网络。
BMC Cancer. 2014 Sep 24;14:710. doi: 10.1186/1471-2407-14-710.
3
Cyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis in cervical cancer cells in vitro and in vivo.
Molecules. 2025 Mar 28;30(7):1507. doi: 10.3390/molecules30071507.
4
Iron overload mediates cytarabine resistance in AML by inhibiting the TP53 signaling pathway.铁过载通过抑制TP53信号通路介导急性髓系白血病对阿糖胞苷的耐药性。
Acta Biochim Biophys Sin (Shanghai). 2025 Feb 28;57(4):646-655. doi: 10.3724/abbs.2025027.
5
Transferrin Receptor 2 in Canine Testicular Tumors: An Emerging Key Role in Seminomas.犬睾丸肿瘤中的转铁蛋白受体2:在精原细胞瘤中发挥新的关键作用
Animals (Basel). 2025 Jan 18;15(2):264. doi: 10.3390/ani15020264.
6
Iron metabolism in a mouse model of hepatocellular carcinoma.肝细胞癌小鼠模型中的铁代谢
Sci Rep. 2025 Jan 16;15(1):2180. doi: 10.1038/s41598-025-86486-x.
7
The oxygen puzzle in FLASH radiotherapy: A comprehensive review and experimental outlook.FLASH放射治疗中的氧难题:全面综述与实验展望
Clin Transl Radiat Oncol. 2024 Sep 18;49:100860. doi: 10.1016/j.ctro.2024.100860. eCollection 2024 Nov.
8
FGFR1 governs iron homeostasis via regulating intracellular protein degradation pathways of IRP2 in prostate cancer cells.FGFR1 通过调控前列腺癌细胞中 IRP2 的细胞内蛋白降解途径来调节铁稳态。
Commun Biol. 2024 Aug 17;7(1):1011. doi: 10.1038/s42003-024-06704-6.
9
Redox-Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer: Molecular Insights and Therapeutic Opportunities.氧化还原调节的铁代谢与卵巢癌中的铁死亡:分子见解与治疗机遇
Antioxidants (Basel). 2024 Jun 28;13(7):791. doi: 10.3390/antiox13070791.
10
Natural products targeting ferroptosis pathways in cancer therapy (Review).天然产物靶向癌症治疗中的铁死亡途径(综述)。
Oncol Rep. 2024 Sep;52(3). doi: 10.3892/or.2024.8782. Epub 2024 Jul 26.
细胞周期蛋白D1b过表达在体外和体内均抑制宫颈癌细胞的增殖并诱导其凋亡。
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4016-23. eCollection 2014.
4
Regulatory effect of iron regulatory protein-2 on iron metabolism in lung cancer.铁调节蛋白-2对肺癌铁代谢的调控作用
Genet Mol Res. 2014 Jul 25;13(3):5514-22. doi: 10.4238/2014.July.25.5.
5
Essential functions of iron-requiring proteins in DNA replication, repair and cell cycle control.需铁蛋白在DNA复制、修复及细胞周期调控中的基本功能。
Protein Cell. 2014 Oct;5(10):750-60. doi: 10.1007/s13238-014-0083-7. Epub 2014 Jul 8.
6
Iron oxide nanoparticles mediated cytotoxicity via PI3K/AKT pathway: role of quercetin.氧化铁纳米颗粒通过PI3K/AKT信号通路介导细胞毒性:槲皮素的作用
Food Chem Toxicol. 2014 Sep;71:106-15. doi: 10.1016/j.fct.2014.06.003. Epub 2014 Jun 14.
7
Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas.静脉注射转铁蛋白偶联树突状聚合物胶束对前列腺癌的治疗效果。
Nanomedicine (Lond). 2014 Apr;9(4):421-34. doi: 10.2217/NNM.13.25.
8
Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies.核糖核苷酸还原酶与癌症:生物学机制及靶向治疗
Oncogene. 2015 Apr 16;34(16):2011-21. doi: 10.1038/onc.2014.155. Epub 2014 Jun 9.
9
Immunohistochemical demonstration of transferrin receptor 1 and 2 in human hepatocellular carcinoma tissue.人肝细胞癌组织中转铁蛋白受体1和2的免疫组织化学检测
Hepatogastroenterology. 2014 Mar-Apr;61(130):426-30.
10
Ribonucleotide reductase metallocofactor: assembly, maintenance and inhibition.核糖核苷酸还原酶金属辅因子:组装、维持与抑制
Front Biol (Beijing). 2014 Jan 2;9(2):104-113. doi: 10.1007/s11515-014-1302-6.